Desmoid Tumor Research Foundation
Menu

Sign Up for Updates

DTRF Updates

Sorafenib Extends PFS in Desmoid TumorsNIH-funded study shows sorafenib improves progression-free survival for patient

Tegavivint Trial LaunchesIterion Therapeutics, formerly known as Beta Cat Pharmaceuticals, today announced that it has initiated a multi-center Phase I clinical study of Tegavivint

Abstract for Phase II Pazopanib TrialDT are a group of locally aggressive tumors of fibroblastic origin that can lead

ASCO Presentation for Phase II Pazopanib TrialPazopanib versus IV methotrexate/vinblastine in
adult patients

DTRF’s 2018 Grant AwardsGerlinde Wernig, MD, Assistant Professor of Pathology, Standford Univesity School

Upcoming Clinical TrialsVisit our clinical trials page to find information on all desmoid tumor clinical trials.

Int’l DTRF Desmoid Tumor Research WorkshopSave the date for the Fifth Annual DTRF International Desmoid Tumor Research Workshop

Desmoid Tumour Foundation of CanadaThey donated $85,000 to DTRF research initiatives in 2018!

Click here for archive of UPDATES

Running for Answers

Thank you for joining us for the 9th Annual Running for Answers 5K and Kids’ Fun Run on Sunday, September 23rd!

Sign Up for Updates

  TOP